ReferenceID 5678
The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice
Br J Pharmacol
BACKGROUND AND PURPOSE: Alzheimer's disease (AD) is the most prevalent disease associated with cognitive dysfunction. Current AD therapeutic agents have several gastrointestinal or psychological adverse effects and there
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 5678
- Evidence Id
- 22268
- Core Evidence Id
- 22268
- Source Reference Id
- 4600
- Herb2 Reference Id
- HBREF005397
- Subject Paper Key
- HBIN034527_32133639
- Pubmed Id
- 32133639
- Doi
- 10.1111/bph.15042
- Paper Title
- The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice
- Paper Abstract
- BACKGROUND AND PURPOSE: Alzheimer's disease (AD) is the most prevalent disease associated with cognitive dysfunction. Current AD therapeutic agents have several gastrointestinal or psychological adverse effects and therefore, novel therapeutic agents with fewer adverse effects must be developed. Previously, we demonstrated that oleanolic acid, which is similar in chemical structure to maslinic acid, ameliorates cognitive impairment through the activation of tropomyosin receptor kinase (TrkB)-ERK-cAMP response element-binding protein (CREB) phosphorylation and increased levels of brain-derived neurotrophic factor (BDNF). In the present study, we investigate the effect of maslinic acid on cholinergic blockade-induced memory impairment in mice. METHODS AND KEY RESULTS: Maslinic acid reversed scopolamine-induced memory impairment, as determined by the Y-maze, passive avoidance and Morris water maze tests. In addition, we also observed that ERK-CREB, PI3K and PKB (Akt) phosphorylation levels were increased by maslinic acid administration in the mouse hippocampus. Moreover, we determined that the effects of maslinic acid on scopolamine-induced memory impairment in the passive avoidance test were abolished by a specific TrkB receptor antagonist (ANA-12). Additionally, we observed similar temporal changes in the expression levels between BDNF and tissue plasminogen activator in the hippocampus. CONCLUSION AND IMPLICATIONS: These findings suggest that maslinic acid enhances cognitive function through the activation of BDNF and its downstream pathway signalling in the hippocampus and that it might be a potential therapeutic agent for cognitive decline, such as that observed in AD.
- Journal
- Br J Pharmacol
- Publish Year
- 2020
- Experiment Subject
- mouse
- Experiment Type
- Animal Experiment
- Phenotype Related
- Alzheimer's Disease; Cognitive Impairment; Cognitive Dysfunction; Cognitive Decline
- Paper Title Cn
- Paper Title En
- The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice
- Bilingual Status
- semi_complete